Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Fidock

Showing results (161-170 of 303) with videos related to

Pageof 31
Sort By:
Cell|August 16, 2014
Supergenomic network compression and the discovery of EXP1 as a glutathione transferase inhibited by artesunateAndreas Martin Lisewski, Joel P Quiros, Caroline L Ng, et al.
Cell Chemical Biology|August 13, 2024
Mixed alkyl/aryl phosphonates identify metabolic serine hydrolases as antimalarial targetsJohn M Bennett, Sunil K Narwal, Stephanie Kabeche, et al.
Plos Pathogens|February 7, 2022
Evidence for the early emergence of piperaquine-resistant Plasmodium falciparum malaria and modeling strategies to mitigate resistanceJennifer L Small-Saunders, Laura M Hagenah, Kathryn J Wicht, et al.
Nature Communications|January 23, 2021
Artemisinin-resistant K13 mutations rewire Plasmodium falciparum's intra-erythrocytic metabolic program to enhance survivalSachel Mok, Barbara H Stokes, Nina F Gnädig, et al.
Biorxiv : the Preprint Server for Biology|January 23, 2024
Mixed Alkyl/Aryl Phosphonates Identify Metabolic Serine Hydrolases as Antimalarial TargetsJohn M Bennett, Sunil K Narwal, Stephanie Kabeche, et al.
ACS Infectious Diseases|September 15, 2023
Covalent Macrocyclic Proteasome Inhibitors Mitigate Resistance in <i>Plasmodium falciparum</i>John M Bennett, Kurt E Ward, Ryan K Muir, et al.
Plos Genetics|February 15, 2013
Mitotic evolution of Plasmodium falciparum shows a stable core genome but recombination in antigen familiesSelina E R Bopp, Micah J Manary, A Taylor Bright, et al.
Journal of Medicinal Chemistry|September 8, 2025
Structure-Activity Relationships of 3-Hydroxypropanamidines (HPAs) with Potent In Vivo Antimalarial ActivitySaskia Klein, Alena Moritz, Lais Pessanha de Carvalho, et al.
Plos Biology|April 23, 2015
Targeting the cell stress response of Plasmodium falciparum to overcome artemisinin resistanceCon Dogovski, Stanley C Xie, Gaetan Burgio, et al.
Molecular Microbiology|April 14, 2016
CRISPR-Cas9-modified pfmdr1 protects Plasmodium falciparum asexual blood stages and gametocytes against a class of piperazine-containing compounds but potentiates artemisinin-based combination therapy partner drugsCaroline L Ng, Giulia Siciliano, Marcus C S Lee, et al.
Pageof 31

Showing results (161-170 of 303) with videos related to

Sort By:
Pageof 31
Cell|August 16, 2014
Supergenomic network compression and the discovery of EXP1 as a glutathione transferase inhibited by artesunateAndreas Martin Lisewski, Joel P Quiros, Caroline L Ng, et al.
Cell Chemical Biology|August 13, 2024
Mixed alkyl/aryl phosphonates identify metabolic serine hydrolases as antimalarial targetsJohn M Bennett, Sunil K Narwal, Stephanie Kabeche, et al.
Plos Pathogens|February 7, 2022
Evidence for the early emergence of piperaquine-resistant Plasmodium falciparum malaria and modeling strategies to mitigate resistanceJennifer L Small-Saunders, Laura M Hagenah, Kathryn J Wicht, et al.
Nature Communications|January 23, 2021
Artemisinin-resistant K13 mutations rewire Plasmodium falciparum's intra-erythrocytic metabolic program to enhance survivalSachel Mok, Barbara H Stokes, Nina F Gnädig, et al.
Biorxiv : the Preprint Server for Biology|January 23, 2024
Mixed Alkyl/Aryl Phosphonates Identify Metabolic Serine Hydrolases as Antimalarial TargetsJohn M Bennett, Sunil K Narwal, Stephanie Kabeche, et al.
ACS Infectious Diseases|September 15, 2023
Covalent Macrocyclic Proteasome Inhibitors Mitigate Resistance in <i>Plasmodium falciparum</i>John M Bennett, Kurt E Ward, Ryan K Muir, et al.
Plos Genetics|February 15, 2013
Mitotic evolution of Plasmodium falciparum shows a stable core genome but recombination in antigen familiesSelina E R Bopp, Micah J Manary, A Taylor Bright, et al.
Journal of Medicinal Chemistry|September 8, 2025
Structure-Activity Relationships of 3-Hydroxypropanamidines (HPAs) with Potent In Vivo Antimalarial ActivitySaskia Klein, Alena Moritz, Lais Pessanha de Carvalho, et al.
Plos Biology|April 23, 2015
Targeting the cell stress response of Plasmodium falciparum to overcome artemisinin resistanceCon Dogovski, Stanley C Xie, Gaetan Burgio, et al.
Molecular Microbiology|April 14, 2016
CRISPR-Cas9-modified pfmdr1 protects Plasmodium falciparum asexual blood stages and gametocytes against a class of piperazine-containing compounds but potentiates artemisinin-based combination therapy partner drugsCaroline L Ng, Giulia Siciliano, Marcus C S Lee, et al.
Pageof 31